Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Jayachandran, Muthuvel ^a   Miller, Virginia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

17 estradiol; Endothelial nitric oxide synthase; Heat shock protein; Hormones; Inducible nitric oxide synthase; Megakaryocytes; Nitric oxide synthase

Indexed keywords

CALMODULIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HORMONE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL STRAIN COS7; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 0036299713     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00950.2001     Document Type: Article

References (58)

1. Immunological detection of activated platelets in clinical disorders
2. Flow cytometric measurement of platelet function and reticulated platelets
3. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17β-estradiol and medroxyprogesterone acetate in postmenopausal women
4. Chronic increases in blood flow upregulate endothelin-B receptors in arterial smooth muscle
5. Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries
6. Steroid receptor family: Structure and functions
7. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae
8. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
9. Hormone replacement therapy, inflammation, and hemostasis in elderly women
10. Risk of venous thromboembolism in users of hormone replacement therapy
11. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36
12. Gender differences in platelet GPIIb-IIIa activation
13. Control of estrogen receptor ligand binding by Hsp 90
14. Dynamic activation of endothelial nitric oxide synthase by Hsp 90
15. Are low-dose oral contraceptives safer and better?
16. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism
17. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study
18. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1
19. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits: Quantification of cellular proliferation by bromodeoxyuridine
20. Sex difference in platelet aggregation detected by new aggregometry using light scattering
21. Physiological concentration of 17 beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: Role of NO
22. Effect of estrogen on isoforms of nitric oxide synthase: Possible mechanism of anti-atherosclerotic effect of estrogen
23. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells
24. Hormone replacement therapy with estradiol and risk of venous thrombo-embolism. A population-based case-control study
25. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries
26. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
27. Platelet-derived nitric oxide and coronary risk factors
28. 2-adrenergic receptor: The role of β-blocker with NO releasing action
29. Sex related differences in platelet function: The effect of aspirin
30. Human megakaryocytes and platelets contain the estrogen receptor β and androgen receptor (AR): Testosterone regulates AR expression
31. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae
32. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction
33. Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women
34. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism
35. Cellular functions of the plasma membrane estrogen receptor
36. Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women
37. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets
38. Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions
39. Influence of hormones on platelet intracellular calcium
40. Effect of 17 beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis
41. Pathophysiology of venous thromboembolism
42. Peptide antagonists of the human estrogen receptor
43. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
44. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
45. Effects of estradiol and progesterone on platelet calcium responses
46. Human vascular endothelial cells contain membrane binding site for estradiol, which mediate rapid intracellular signaling
47. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis
48. Inhibition of surface-induced platelet activation by nitric oxide
49. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia
50. The estrogen receptor is present in human megakaryocytes
51. Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women
52. Modulation of nitric oxide synthase (NOS) activity by nicotine
53. Mortality and morbidity in transsexual subjects treated with cross-sex hormones
54. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study
55. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells
56. Purification of the major mammalian heat shock proteins
57. Molecular mechanisms of steroid hormone action
58. Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity